SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001689813-22-000046
Filing Date
2022-05-10
Accepted
2022-05-10 17:29:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2022bhvndefa14asocialmedia.htm DEFA14A 29209
2 GRAPHIC sm1.jpg GRAPHIC 160076
3 GRAPHIC sm2.jpg GRAPHIC 177783
4 GRAPHIC sm3.jpg GRAPHIC 221395
  Complete submission text file 0001689813-22-000046.txt   800658
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38080 | Film No.: 22911201
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences